| __timestamp | ADMA Biologics, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 8494000000 |
| Thursday, January 1, 2015 | 7015946 | 9046000000 |
| Friday, January 1, 2016 | 7688238 | 9095000000 |
| Sunday, January 1, 2017 | 6229587 | 10554000000 |
| Monday, January 1, 2018 | 3926120 | 10775000000 |
| Tuesday, January 1, 2019 | 2343848 | 11355000000 |
| Wednesday, January 1, 2020 | 5907013 | 12340000000 |
| Friday, January 1, 2021 | 3646060 | 14277000000 |
| Saturday, January 1, 2022 | 3613764 | 14135000000 |
| Sunday, January 1, 2023 | 3300000 | 15048000000 |
| Monday, January 1, 2024 | 17232000000 |
Cracking the code
In the world of pharmaceuticals and biotechnology, innovation is the lifeblood of progress. Johnson & Johnson, a titan in the healthcare industry, and ADMA Biologics, Inc., a specialized biopharmaceutical company, present a fascinating contrast in their investment strategies. Over the past decade, Johnson & Johnson has consistently allocated a significant portion of its resources to research and development, with annual expenses peaking at approximately $15 billion in 2023. This represents a steady increase of about 77% from 2014. In contrast, ADMA Biologics, Inc. has shown a more modest investment, with R&D expenses reaching around $3.3 million in 2023, a decrease of 65% from its 2014 peak. This disparity highlights the differing scales and strategies of these companies, with Johnson & Johnson's robust investment underscoring its commitment to innovation on a global scale.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds